123 related articles for article (PubMed ID: 22767220)
41. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
[TBL] [Abstract][Full Text] [Related]
42. The relationship between secretory leukocyte protease inhibitor expression and Epstein-Barr virus status among patients with nasopharyngeal carcinoma.
Tse KP; Wu CS; Hsueh C; Chang KP; Hao SP; Chang YS; Tsang NM
Anticancer Res; 2012 Apr; 32(4):1299-307. PubMed ID: 22493362
[TBL] [Abstract][Full Text] [Related]
43. Stat6 activity-related Th2 cytokine profile and tumor growth advantage of human colorectal cancer cells in vitro and in vivo.
Li BH; Xu SB; Li F; Zou XG; Saimaiti A; Simayi D; Wang YH; Zhang Y; Yuan J; Zhang WJ
Cell Signal; 2012 Mar; 24(3):718-25. PubMed ID: 22108090
[TBL] [Abstract][Full Text] [Related]
44. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
[TBL] [Abstract][Full Text] [Related]
45. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
46. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
[TBL] [Abstract][Full Text] [Related]
47. Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism.
Shibata MA; Ito Y; Morimoto J; Otsuki Y
Carcinogenesis; 2004 Oct; 25(10):1887-98. PubMed ID: 15180944
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of EGFR pathway signaling and the metastatic potential of breast cancer cells by PA-MSHA mediated by type 1 fimbriae via a mannose-dependent manner.
Liu ZB; Hou YF; Zhu J; Hu DL; Jin W; Ou ZL; Di GH; Wu J; Shen ZZ; Shao ZM
Oncogene; 2010 May; 29(20):2996-3009. PubMed ID: 20228837
[TBL] [Abstract][Full Text] [Related]
49. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
Schmid M; Fellermann K; Fritz P; Wiedow O; Stange EF; Wehkamp J
J Leukoc Biol; 2007 Apr; 81(4):907-15. PubMed ID: 17200145
[TBL] [Abstract][Full Text] [Related]
50. CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy.
Rostoker R; Ben-Shmuel S; Rashed R; Shen Orr Z; LeRoith D
Breast Cancer Res; 2016 May; 18(1):51. PubMed ID: 27179633
[TBL] [Abstract][Full Text] [Related]
51. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
[TBL] [Abstract][Full Text] [Related]
52. Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells.
Sayers KT; Brooks AD; Sayers TJ; Chertov O
PLoS One; 2014; 9(8):e104223. PubMed ID: 25110884
[TBL] [Abstract][Full Text] [Related]
53. Secretory leukocyte peptidase inhibitor and lung cancer.
Nukiwa T; Suzuki T; Fukuhara T; Kikuchi T
Cancer Sci; 2008 May; 99(5):849-55. PubMed ID: 18380788
[TBL] [Abstract][Full Text] [Related]
54. Secretory leukocyte protease inhibitor is a proliferation and survival factor for pancreatic cancer cells.
Zuo J; Zhang C; Ren C; Pang D; Li Y; Xie X; Tang Z; Jiang X
Clin Transl Oncol; 2015 Apr; 17(4):314-21. PubMed ID: 25319722
[TBL] [Abstract][Full Text] [Related]
55. Secretory leukoprotease inhibitor is required for efficient quercetin-mediated suppression of TNFα secretion.
De Santis S; Kunde D; Serino G; Galleggiante V; Caruso ML; Mastronardi M; Cavalcanti E; Ranson N; Pinto A; Campiglia P; Santino A; Eri R; Chieppa M
Oncotarget; 2016 Nov; 7(46):75800-75809. PubMed ID: 27716626
[TBL] [Abstract][Full Text] [Related]
56. The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
Xie W; Zhang H; Qin S; Zhang J; Fan X; Yin Y; Liang R; Long H; Yi W; Fu D; Ma C; Lv M; Yu F
Gene; 2019 Dec; 720():144088. PubMed ID: 31476404
[TBL] [Abstract][Full Text] [Related]
57. The tumor-promoting effect of TNF-alpha involves the induction of secretory leukocyte protease inhibitor.
Devoogdt N; Revets H; Kindt A; Liu YQ; De Baetselier P; Ghassabeh GH
J Immunol; 2006 Dec; 177(11):8046-52. PubMed ID: 17114478
[TBL] [Abstract][Full Text] [Related]
58. Human buccal epithelium acquires microbial hyporesponsiveness at birth, a role for secretory leukocyte protease inhibitor.
Menckeberg CL; Hol J; Simons-Oosterhuis Y; Raatgeep HR; de Ruiter LF; Lindenbergh-Kortleve DJ; Korteland-van Male AM; El Aidy S; van Lierop PP; Kleerebezem M; Groeneweg M; Kraal G; Elink-Schuurman BE; de Jongste JC; Nieuwenhuis EE; Samsom JN
Gut; 2015 Jun; 64(6):884-93. PubMed ID: 25056659
[TBL] [Abstract][Full Text] [Related]
59. Secretory Leukocyte Protease Inhibitor (SLPI): Emerging Roles in CNS Trauma and Repair.
Hannila SS
Neuroscientist; 2015 Dec; 21(6):630-6. PubMed ID: 25118190
[TBL] [Abstract][Full Text] [Related]
60. Paracrine SLPI secretion upregulates MMP-9 transcription and secretion in ovarian cancer cells.
Hoskins E; Rodriguez-Canales J; Hewitt SM; Elmasri W; Han J; Han S; Davidson B; Kohn EC
Gynecol Oncol; 2011 Sep; 122(3):656-62. PubMed ID: 21676452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
